Adenosine receptors in post‐mortem human brain

1 Adenosine A2‐like binding sites were characterized in post‐mortem human brain membranes by examining several compounds for their ability to displace [3H]‐CGS 21680 (2[p‐(2 carboxyethyl)‐phenethylamino]‐5′‐N‐ethylcarboxamido adenosine) binding. 2 Two A2‐like binding sites were identified in the striatum. 3 The more abundant striatal site was similar to the A2a receptor previously described in rat striatum, both in its pharmacological profile and striatal localization. 4 The less abundant striatal site had a pharmacological profile similar to that of the binding site characterized in the other brain regions examined. This was intermediate in character between A1 and A2 and may represent another adenosine receptor subtype. 5 The co‐purification of [3H]‐CGS 21680 binding during immunoisolation of human striatal cholinergic membranes was used to assess the possible cholinergic localization of A2‐like binding sites in the human striatum. Only the more abundant striatal site co‐purified with cholinergic membranes. This suggests that this A2a‐like site is present on cholinergic neurones in the human striatum.

[1]  M. Williams,et al.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[2]  K. Siddle,et al.  Immunoaffinity purification of intact, metabolically active, cholinergic nerve terminals from mammalian brain. , 1984, The Biochemical journal.

[3]  V. P. Whittaker,et al.  Identification of a Cholinergic‐Specific Antigen Chol‐1 as a Ganglioside , 1982, Journal of neurochemistry.

[4]  D. Cooper,et al.  Adenosine receptor agonists inhibit inositol phosphate accumulation in rat striatal slices. , 1987, European journal of pharmacology.

[5]  S. Synder,et al.  Autoradiographic localization of adenosine receptors in rat brain using [3H]cyclohexyladenosine , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  J. Hardy,et al.  Metabolically Active Synaptosomes Can Be Prepared from Frozen Rat and Human Brain , 1983, Journal of neurochemistry.

[7]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[8]  B. Fredholm,et al.  How does adenosine inhibit transmitter release? , 1988, Trends in pharmacological sciences.

[9]  G. Lu,et al.  Adenosine Receptor Subtypes: Binding Studies , 1987 .

[10]  G. Kreutzberg,et al.  5′-Nucleotidase in the Nervous System , 1986 .

[11]  C. Londos,et al.  Two distinct adenosine-sensitive sites on adenylate cyclase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Thierry,et al.  Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular and cellular distribution. , 1979, Molecular pharmacology.

[13]  T. Palmer,et al.  Adenosine receptors , 1995, Neuropharmacology.

[14]  S H Snyder,et al.  Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines. , 1981, Life sciences.

[15]  Margarete Müller,et al.  ADENOSINE REGULATES VIA TWO DIFFERENT TYPES OF RECEPTORS, THE ACCUMULATION OF CYCLIC AMP IN CULTURED BRAIN CELLS , 1979, Journal of neurochemistry.

[16]  G. Isenberg,et al.  Ionic Channels and Adenosine in Isolated Heart Cells , 1987 .

[17]  P. Ferretti,et al.  Putative Cholinergic‐Specific Gangliosides in Guinea Pig Forebrain , 1986, Journal of neurochemistry.

[18]  J. Luzio,et al.  Ectoenzymes control adenosine modulation of immunoisolated cholinergic synapses , 1987, Nature.

[19]  P. Dodd,et al.  ADENOSINE RECEPTORS IN POST‐MORTEM HUMAN CEREBRAL CORTEX AND THE EFFECT OF CARBAMAZEPINE , 1986, Clinical and experimental pharmacology & physiology.

[20]  P. Richardson.  Isolation of Cholinergic Nerve Terminals , 1988 .

[21]  R. G. Browne,et al.  4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants. , 1990, Journal of medicinal chemistry.

[22]  G. Lu,et al.  Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. , 1986, Molecular pharmacology.

[23]  B. Weeks,et al.  Species differences in high‐affinity adenosine A2 binding sites in striatal membranes from mammalian brain , 1988 .

[24]  M. Reddington,et al.  Both A1 and A2a Purine Receptors Regulate Striatal Acetylcholine Release , 1990, Journal of neurochemistry.

[25]  G. A. West,et al.  The Negative Chronotropic Effect of Adenosine in Sinus Node Cells , 1987 .

[26]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[27]  T. Dunwiddie.  The physiological role of adenosine in the central nervous system. , 1985, International review of neurobiology.

[28]  J. Fastbom,et al.  The distribution of adenosine a1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals , 1987, Neuroscience.

[29]  D. Cooper,et al.  Adenosine Receptors and Adenylate Cyclase Interactions , 1983 .

[30]  J. Luzio,et al.  The properties and extracellular location of 5'-nucleotidase of the rat fat-cell plasma membrane. , 1975, The Biochemical journal.

[31]  V. P. Whittaker,et al.  Confirmation of the Cholinergic Specificity of the Chol‐1 Gangliosides in Mammalian Brain Using Affinity‐Purified Antisera and Lesions Affecting the Cholinergic Input to the Hippocampus , 1989, Journal of neurochemistry.

[32]  T. Dunwiddie,et al.  Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum. , 1990, The Journal of pharmacology and experimental therapeutics.

[33]  M. Lagarde,et al.  Characterization of A‐2 Receptors in Postmortem Human Pineal Gland , 1990, Journal of neurochemistry.

[34]  R. G. Browne,et al.  4‐Amino(1,2,4)triazolo(4,3‐a)quinoxalines. A Novel Class of Potent Adenosine Receptor Antagonists and Potential Rapid‐Onset Antidepressants. , 1991 .

[35]  P. Richardson.  Choline Uptake and Metabolism in Affinity‐Purified Cholinergic Nerve Terminals from Rat Brain , 1986, Journal of neurochemistry.

[36]  K. Jacobson,et al.  The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. , 1991, Molecular pharmacology.

[37]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.